Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole

Arab J Gastroenterol. 2011 Mar;12(1):44-7. doi: 10.1016/j.ajg.2010.11.001. Epub 2011 Jan 21.

Abstract

Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially - available combination of two antibiotics - spiramycin and metronidazole - commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects*
  • Antiprotozoal Agents / adverse effects*
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Chemical and Drug Induced Liver Injury / physiopathology
  • Chemical and Drug Induced Liver Injury / therapy*
  • Drug Combinations
  • Humans
  • Liver Transplantation
  • Male
  • Metronidazole / adverse effects*
  • Spiramycin / adverse effects*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antiprotozoal Agents
  • Drug Combinations
  • Metronidazole
  • Spiramycin
  • Rodogyl